Treatment strategies for postviral olfactory dysfunction: A systematic review
Samuel N Helman1, Jonah Adler2, Aria Jafari3
1From the Department of Otolaryngology - Head and Neck Surgery, Weill Cornell Medical College, New York, New York.
Allergy and Asthma Proceedings
|March 23, 2022
Summary
Postviral olfactory dysfunction (PVOD) following COVID-19 infection can be treated. Olfactory training is currently the most supported intervention for restoring smell function, though more research is needed.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Evidence-Based Medicine
Background:
- The COVID-19 pandemic has led to a significant rise in postviral olfactory dysfunction (PVOD).
- A current review of PVOD treatments is crucial for enhancing patient care.
- Evidence-based strategies are needed to manage this growing condition.
Purpose of the Study:
- To qualitatively review existing evidence on medical and procedural treatments for PVOD.
- To systematically assess the quality of data and evidence levels for PVOD interventions.
- To develop current treatment recommendations based on scientific evidence.
Main Methods:
- A systematic review identified primary studies on PVOD treatment outcomes.
- Searches of medical literature databases (1998-2020) and reference lists were conducted.
- Validated tools assessed study bias, informing evidence levels and treatment recommendations.
Main Results:
- Twenty-two publications were reviewed, detailing outcomes for various treatments.
- Interventions included alpha-lipoic acid, corticosteroids, minocycline, zinc sulfate, vitamin A, and others.
- The review also examined traditional Chinese acupuncture and olfactory training.
Conclusions:
- Several medical and procedural interventions may accelerate olfactory function recovery in PVOD.
- Olfactory training is identified as a primary, first-line intervention.
- Further research is necessary to establish specific COVID-19-related PVOD treatment guidelines.
Related Concept Videos
Olfactory Receptors: Location and Structure
9.8K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.8K
Drugs Used in Upper Respiratory Disorders: Overview
389
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
389
Olfaction
45.3K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
45.3K
Physiology of Smell and Olfactory Pathway
9.9K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
9.9K
Tonsillitis II: Management
190
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
190
Acute Respiratory Failure-V
223
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
223


